Skip to main content
Equibles

Eversept Partners, LP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1697013 NEW YORK, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,019,826
+$1,925,859 QoQ
Shares Held
377,007
+176.7% QoQ
Ownership
0.379%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#34
of 208 holders
Holding Since
Jun 2023
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. SPRY ranks #41 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 913,880 $121,783,648
2 VERA
Vera Therapeutics, Inc.
 2,212,770 $94,949,960
3 CLDX
Celldex Therapeutics, Inc.
 1,785,941 $66,454,864
4 SNDX
Syndax Pharmaceuticals Inc
 2,798,210 $61,168,870
5 IONS
Ionis Pharmaceuticals Inc
 664,684 $52,702,794
6 TVTX
Travere Therapeutics, Inc.
 798,973 $45,389,656
7 PCVX
Vaxcyte, Inc.
 629,952 $36,619,109
8 GERN
Geron Corp
 18,717,422 $23,958,300

All Filings in SPRY

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,019,826 377,007
2026-03-31 $1,093,967 136,235
2025-12-31 $2,931,058 251,593
2025-09-30 $9,813,935 976,511
2023-06-30 $326,879 48,788